Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Gilead SciencesBiogenAmgenSeattle GeneticsNOVOZYMES A/S/S
SymbolNASDAQ:GILDNASDAQ:BIIBNASDAQ:AMGNNASDAQ:SGENOTCMKTS:NVZMY
Price Information
Current Price$65.07$282.27$220.86$114.75$46.35
52 Week RangeBuyHoldBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyHold
Consensus Price Target$79.32$290.28$221.72$106.00N/A
% Upside from Price Target21.90% upside2.84% upside0.39% upside-7.63% downsideN/A
Trade Information
Market Cap$80.73 billion$49.65 billion$129.83 billion$19.42 billion$13.72 billion
Beta1.091.071.0920.75
Average Volume6,297,7333,116,3412,451,3381,240,44827,585
Sales & Book Value
Annual Revenue$22.13 billion$13.45 billion$23.75 billion$654.70 million$2.28 billion
Price / Sales3.723.795.5330.046.04
Cashflow$7.47 per share$32.56 per share$18.27 per shareN/A$1.73 per share
Price / Cash8.718.6712.09N/A26.84
Book Value$16.39 per share$77.54 per share$18.39 per share$10.38 per share$5.62 per share
Price / Book3.973.6412.0111.058.25
Profitability
Net Income$5.46 billion$4.43 billion$8.39 billion$-222,690,000.00$511 million
EPS$6.15$26.20$14.40($1.65)$1.75
Trailing P/E Ratio10.5810.7715.34N/A26.48
Forward P/E Ratio9.678.5614.04N/A29.15
P/E Growth$3.39$1.49$2.25N/A$2.35
Net Margins12.04%37.91%34.48%-37.97%21.08%
Return on Equity (ROE)37.50%46.14%80.26%-19.17%26.90%
Return on Assets (ROA)13.13%23.53%14.50%-15.99%14.94%
Dividend
Annual Payout$2.52N/A$5.80N/A$0.50
Dividend Yield3.87%N/A2.63%N/A1.08%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio40.98%N/A40.28%N/A28.57%
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.11%0.35%2.54%N/A0.23%
Current Ratio2.96%1.91%2.89%4.86%1.29%
Quick Ratio2.87%1.74%2.59%4.49%0.75%
Ownership Information
Institutional Ownership Percentage80.03%88.03%77.06%92.50%0.18%
Insider Ownership Percentage0.20%0.39%0.25%33.80%N/A
Miscellaneous
Employees11,0007,80021,5001,3026,427
Shares Outstanding1.27 billion180.44 million594.18 million171.39 million297.00 million
Next Earnings Date2/3/2020 (Estimated)2/4/2020 (Estimated)2/4/2020 (Estimated)2/6/2020 (Estimated)1/23/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable
 Gilead SciencesBiogenAmgenSeattle GeneticsNOVOZYMES A/S/S

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel